Prime Medicine, Inc.PRMENASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-195.76M
↓ 76% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-111.43M
Historical baseline
PeriodValueYoY Change
2025$-195.76M+0.3%
2024$-196.34M-5.2%
2023$-186.64M-63.3%
2022$-114.32M-36.2%
2021$-83.91M-9338.2%
2020$-889000.00+59.1%
2019$-2.17M-